COM:PTCBIO
PTC Therapeutics
- Stock
Last Close
36.52
25/09 14:39
Market Cap
2.44B
Beta: -
Volume Today
63.37K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -51.57M - | -93.75M 81.78% | -170.45M 81.80% | -142.11M 16.63% | -79M 44.41% | -128.08M 62.13% | -251.58M 96.42% | -438.16M 74.17% | -523.90M 19.57% | -559.02M 6.70% | -626.60M 12.09% | |
depreciation and amortization | 2.40M - | 2.23M 6.74% | 2.88M 28.68% | 3.29M 14.39% | 17.68M 437.45% | 26.09M 47.53% | 32.18M 23.36% | 84.87M 163.74% | 64.13M 24.43% | 128.84M 100.89% | 236.59M 83.64% | |
deferred income tax | 92.46K - | -19.31M 20,985.61% | 2.30M 111.93% | -199K 108.64% | 199K 200% | -490K 346.23% | 8.83M 1,901.84% | 5.87M 33.49% | 377K 93.58% | -34.28M 9,191.78% | -46.93M 36.92% | |
stock based compensation | 8.43M - | 19.31M 129.14% | 33.98M 75.97% | 35.01M 3.03% | 30.56M 12.71% | 33.25M 8.81% | 42.13M 26.71% | 70.33M 66.91% | 103.51M 47.19% | 110.33M 6.59% | 131.21M 18.92% | |
change in working capital | -12.31M - | 13.20M 207.18% | 4.70M 64.39% | -8.96M 290.74% | 13.23M 247.58% | 14.21M 7.42% | 20.43M 43.76% | 36.91M 80.70% | -23.79M 164.45% | -85.33M 258.73% | -4.00M 95.31% | |
accounts receivables | -3.49M - | -6.91M 98.08% | -14.84M 114.88% | -12.20M 17.78% | -29.59M 142.47% | 11.53M 138.95% | -10.48M 190.96% | -44.99M 329.18% | -48.47M 7.73% | -1.54M 96.82% | ||
inventory | -2.63M - | -1.98M 24.75% | 893K 145.19% | -6.45M 822.73% | -5.82M 9.78% | -3.46M 40.65% | 1.84M 153.27% | 1.80M 2.23% | -6.67M 470.44% | -8.18M 22.72% | ||
accounts payables | 5.18B - | 16.91M 99.67% | 16.98M 0.40% | 4.26M 74.92% | 24.01M 463.77% | 43.11M 79.53% | 13.75M 68.11% | 53.59M 289.82% | 23.41M 56.31% | 27.54M 17.64% | 48.35M 75.54% | |
other working capital | -5.20B - | 2.40M 100.05% | -3.40M 241.86% | 727K 121.39% | 7.87M 983.08% | 6.51M 17.27% | -1.39M 121.31% | -8.03M 478.67% | -4.01M 50.07% | -57.74M 1,339.93% | -42.63M 26.18% | |
other non cash items | 6.05M - | 21.05M 247.97% | 2.25M 89.30% | 9.41M 317.53% | 7.27M 22.73% | 27.38M 276.70% | 49.37M 80.29% | 46.11M 6.60% | 128.33M 178.33% | 82.81M 35.48% | 151.32M 82.75% | |
net cash provided by operating activities | -46.92M - | -57.27M 22.06% | -124.34M 117.09% | -103.57M 16.71% | -10.06M 90.28% | -27.64M 174.68% | -98.64M 256.86% | -194.07M 96.75% | -251.33M 29.51% | -356.65M 41.91% | -158.42M 55.58% | |
investments in property plant and equipment | -845.73K - | -4.66M 451.47% | -2.72M 41.68% | -1.78M 34.71% | -3.10M 74.61% | -15.53M 400.81% | -45.44M 192.59% | -55.98M 23.19% | -85.33M 52.44% | -152.46M 78.67% | -120.62M 20.88% | |
acquisitions net | -77.16M - | -48.89M 36.64% | -4M 91.82% | 38.13M 1,053.35% | 57.12M 49.78% | 128.44M 124.86% | 86.06M 32.99% | |||||
purchases of investments | -156.04M - | -247.80M 58.80% | -223.76M 9.70% | -85.38M 61.84% | -81.37M 4.70% | -68.61M 15.67% | -494.07M 620.07% | -1.45B 193.41% | -543.27M 62.52% | -75.55M 86.09% | -212.48M 181.25% | |
sales maturities of investments | 29.06M - | 107.30M 269.21% | 205.67M 91.68% | 191.63M 6.82% | 174.75M 8.81% | 90.42M 48.26% | 156.27M 72.82% | 944.09M 504.14% | 847.78M 10.20% | 518.19M 38.88% | 156.37M 69.82% | |
other investing activites | -38.13M - | -57.12M 49.78% | -128.44M 124.86% | -86.06M 32.99% | ||||||||
net cash used for investing activites | -127.83M - | -145.17M 13.56% | -20.81M 85.66% | 104.48M 602.05% | 13.12M 87.45% | -42.61M 424.87% | -387.24M 808.73% | -561.55M 45.01% | 219.18M 139.03% | 290.18M 32.39% | -176.74M 160.91% | |
debt repayment | -5.00M - | -49K 99.02% | -11.67M - | -46.16M 295.66% | -2.22M 95.18% | -151.28M 6,701.98% | -381.93M 152.47% | |||||
common stock issued | 131.65M - | 235.98M 79.25% | 2.47M - | 117.92M 4,677.80% | 323.76M 174.56% | 28.09M 91.32% | 23.10M 17.77% | 50M 116.44% | 29.99M 40.01% | |||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 60.79M - | 1.20M 98.03% | 154.06M 12,781.35% | 968K 99.37% | 41.75M 4,213.02% | 13.65M 67.29% | 301.12M 2,105.20% | 686.78M 128.08% | 269.23M - | 998.34M 270.82% | ||
net cash used provided by financing activities | 187.44M - | 237.13M 26.51% | 154.06M 35.03% | 968K 99.37% | 44.22M 4,467.98% | 131.57M 197.55% | 613.21M 366.07% | 668.72M 9.05% | 20.88M 96.88% | 167.95M 704.48% | 646.40M 284.87% | |
effect of forex changes on cash | -350K - | -639K 82.57% | -1.58M 147.89% | 6.20M 491.35% | -3.61M 158.25% | -1.30M 63.92% | 7.69M 690.02% | -7.82M 201.73% | -2.77M 64.56% | 3.11M 212.34% | ||
net change in cash | 12.69M - | 34.33M 170.59% | 8.27M 75.90% | 299K 96.39% | 53.47M 17,783.28% | 57.71M 7.92% | 126.03M 118.40% | -79.22M 162.85% | -19.09M 75.90% | 98.71M 616.95% | 314.17M 218.28% | |
cash at beginning of period | 2.73M - | 15.41M 465.51% | 49.75M 222.75% | 58.02M 16.63% | 58.32M 0.52% | 111.79M 91.68% | 169.50M 51.62% | 295.53M 74.35% | 216.31M 26.80% | 197.22M 8.83% | 279.83M 41.89% | |
cash at end of period | 15.41M - | 49.75M 222.74% | 58.02M 16.63% | 58.32M 0.52% | 111.79M 91.68% | 169.50M 51.62% | 295.53M 74.35% | 216.31M 26.80% | 197.22M 8.83% | 295.93M 50.05% | 594.00M 100.73% | |
operating cash flow | -46.92M - | -57.27M 22.06% | -124.34M 117.09% | -103.57M 16.71% | -10.06M 90.28% | -27.64M 174.68% | -98.64M 256.86% | -194.07M 96.75% | -251.33M 29.51% | -356.65M 41.91% | -158.42M 55.58% | |
capital expenditure | -845.73K - | -4.66M 451.47% | -2.72M 41.68% | -1.78M 34.71% | -3.10M 74.61% | -15.53M 400.81% | -45.44M 192.59% | -55.98M 23.19% | -85.33M 52.44% | -152.46M 78.67% | -120.62M 20.88% | |
free cash flow | -47.77M - | -61.94M 29.66% | -127.06M 105.14% | -105.34M 17.09% | -13.16M 87.50% | -43.17M 227.95% | -144.08M 233.74% | -250.05M 73.55% | -336.66M 34.64% | -509.11M 51.22% | -279.04M 45.19% |
All numbers in (except ratios and percentages)